Navigation Links
Angeion Corporation Reports Third Quarter Fiscal 2011 Operating Results
Date:9/1/2011

iagnostic products and claims associated with our prior cardiac stimulation products; (10) our ability to defend our existing intellectual property and obtain protection for intellectual property we develop in the future; (11) our ability to develop and maintain an effective system of internal controls and procedures and disclosure controls and procedures; (12) our dependence on third-party vendors and (13) the ability of new members of our senior management to make a successful transition into their new roles and for all members of senior management to ultimately develop and implement a strategic plan. Additional information with respect to the risks and uncertainties faced by the Company may be found in, and the above discussion is qualified in its entirety by, the other risk factors that are described from time to time in the Company’s Securities and Exchange Commission reports, including the Annual Report on Form 10-K for the year ended October 31, 2010. Contact:

Robert M. Wolf

Joe Dorame, Robert Blum, Joe DiazAngeion Corporation

Lytham Partners, LLCChief Financial Officer

(602) 889-9700(651) 766-4874

angn@lythampartners.comANGEION CORPORATION AND SUBSIDIARIESConsolidated Balance SheetsJuly 31, 2011 and October 31, 2010(In thousands except share and per share data)July 31,2011October 31,2010ASSETS(Unaudited)Current Assets:Cash and cash equivalents$   8,084$   6,943Short-term investments9642,721Accounts receivable, net of allowance for doubtful accounts of $46 and $100, respectively4,7015,221Inventories, net of obsolescence reserve of $572 and $599, respectively4,1313,697Prepaid expenses and other current assets 246270Total Current Assets18,12618,852Noncurrent investments-722Property and equipment, net of accumulated depreciation of $3,706 and $3,649, respectively492528Intangible assets, net1,2041,279Total Assets$  19,822$  21,381LIABILI
'/>"/>

SOURCE Angeion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
11. Immunosyn Corporation Releases SF-1019 Study Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 Research and Markets ... (CAS 103-90-2) Market Research Report 2014" report to ... Market Research Report 2014 presents comprehensive data on paracetamol ... , Asia , North ... includes paracetamol (acetaminophen) description, covers its application areas and ...
(Date:9/15/2014)... 15, 2014  MedExpress Urgent Care, a national leader in ... flu shots for ages four and up at each of ... get their flu shot early. According to ... of June, making late summer and early fall an ideal ... Vice President of Provider and Clinical Quality, Thomas Pangburn ...
(Date:9/15/2014)... PLYMOUTH MEETING, Pa. , Sept. 15, 2014 /PRNewswire/ ... today that it has met the stringent listing criteria ... has transferred to this U.S. stock exchange from the ... its current ticker symbol, "INO." NASDAQ ... Market, maintains the highest initial listing standards of any ...
Breaking Medicine Technology:Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 2Paracetamol (Acetaminophen) (CAS 103-90-2) Market Research Report 2014 3MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3
... TOPAZ Technologies, a leading provider of biomedical research ... ML Weekes & Company, a professional services firm ... strategic partnership.  As a result of this partnership, ... solution through ML Weekes & Company,s RAMS grantsERA ...
... Texas, Nov. 16, 2010 Argon Medical Devices, Inc. ... licensing agreement with Rex Medical, LP ("Rex Medical") for ... dialysis catheter ™ on a global basis. UltraStream ™ ... patients receiving dialysis treatments. Argon will be ...
Cached Medicine Technology:TOPAZ Technologies and ML Weekes & Company Announce Partnership 2TOPAZ Technologies and ML Weekes & Company Announce Partnership 3Argon Medical Devices Announces Exclusive License and Distribution Agreement for 'UltraStream™' Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... September 16, 2014 The Fertility Centers ... with Fairfax Egg Bank. The collaboration will give patients ... donor egg offering at the Fertility Centers of New ... and offers the nation’s largest selection of frozen donor ... several reasons:, , The Donor is ...
(Date:9/15/2014)... 16, 2014 The team of defective ... Danis & Lowe report that the company behind ... responsible for the injuries that a woman sustained after ... stress urinary incontinence (SUI). , Carey Danis & Lowe ... litigation and personal injury law. The St. Louis law ...
(Date:9/15/2014)... Phoenix, AZ (PRWEB) September 16, 2014 ... Law group in Phoenix Arizona announces one flat attorney ... in ensuring that clients retain the largest portion possible ... cover medical expenses, lost wages and damaged personal property. ... fee promise” to clients that simply states that no ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 1Heart ... training for most staff of Regency Park Oak ... collaboration with their Executive Director Gladys Broxton. This ... and initiative of 1Heart Shirley Billedo and Regency ... Artiga, Marketing Director Jeanine Hernandez and Activities Coordinator ...
(Date:9/15/2014)... 2014 Aging skin inevitably wrinkles, thins and ... is loss of collagen production. By age 60, skin ... to this slow down. Collagen holds up skin structure. , ... be boosted. There are several ways to do this, but ... cells (non-embryonic). , "The cost is higher than other types ...
Breaking Medicine News(10 mins):Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Carey Danis & Lowe Reports On $73 Million Boston Scientific Verdict 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 2Health News:Hastings And Hastings Announces One Flat Attorney Fee For Personal Injury Cases 3Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 2Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 3Health News:1Heart Caregiver Services Training Director Randolph Neil Conducted In-Service Training at Regency Park Oak Knoll Pasadena 4Health News:A Superior Way to Make Skin Younger and Assure Continual Collagen Production, from Sublime Beauty® 2
... Fla. (Feb. 01, 2010) A research team from ... of transplanted hepatocyte (liver) cells in animal models severely ... whether and how transplanted hepatocytes were able to efficiently ... this study are published in the current double issue ...
... ... in providing accurate information on sexuality and toys for grown-ups, is proud to announce ... ... Vibrations ( www.goodvibes.com ), the legendary San Francisco-based company that takes pride in providing ...
... Partnership ... IT foundation to grow and maintain business, profitability , ... Austin, Texas (PRWEB) February 1, 2010 -- Pivot ... medium-sized businesses, today announced a partnership agreement with Brookside Technology Partners, Inc., an Austin-based ...
... , ATLANTA , Feb. 1 ... has launched a national campaign to promote physical activity and ... get up and dance. In partnership with Children,s Miracle Network, ... to submit 30-second home videos of their family,s best dance ...
... earlier detection and treatment, study suggests , MONDAY, Feb. ... rheumatoid arthritis long before a person notices symptoms, say ... and chemokines whose levels increase significantly as much as ... , People who receive an early and accurate diagnosis ...
... ... today that it has released a new version of its PASS Rx system. , ... Morrisville, NC (PRWEB) February 1, 2010 ... that it has released a new version of its PASS Rx system. PASS Rx ...
Cached Medicine News:Health News:Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes 2Health News:G Marks the Spot: Good Vibrations Proclaims February as National G-Spot Month -- Sex Toy Company Says "It Most Certainly Does Exist!" 2Health News:G Marks the Spot: Good Vibrations Proclaims February as National G-Spot Month -- Sex Toy Company Says "It Most Certainly Does Exist!" 3Health News:Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs 2Health News:Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs 3Health News:Dance Your Child's Way to a Healthy Body and Happy Heart 2Health News:Long Before Symptoms, Blood May Reveal Rheumatoid Arthritis 2Health News:Centice Corporation Enhances the PASS Rx System with its Version 3.0 Software Update 2
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
eValuator fixed-curve diagnostic electrophysiology catheters offer an effective balance between clinical performance and cost....
... Two high performance technologies - Quantum™ ... shaft platform - unite in the ... a high dilatation force balloon with ... Laser bonded Maverick® shaft technology improves ...
Medicine Products: